IM Cannabis Agrees Sale of European Assets to Slil.com for C$3M
IM Cannabis has signed a definitive agreement to sell IMC Holdings and its Europe-focused assets to Slil.com Holding, aiming to improve shareholders’ equity by about C$3 million and simplify the group. Slil will assume retained liabilities up to roughly C$9.4 million. IM Cannabis will concentrate on its Israeli medical cannabis operations, including Adjupharm GmbH moving with IMC Holdings, while investors weigh financial stress and the related-party nature of the deal.